Company profile

Ticker
AZN
Exchange
Website
CEO
Pascal Soriot
Employees
Location
Fiscal year end
Former names
Zeneca Group PLC
SEC CIK

AZN stock data

(
)

Calendar

3 Mar 20
11 Jul 20
31 Dec 20

News

Company financial data Financial data

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
19 Dec 19 AstraZeneca Common Stock Buy Aquire P No 0 12,946,900 0 12,946,900
7 Oct 19 AstraZeneca Common Stock Buy Aquire P No 19 425,000 8.08M 14,650,334
7 Oct 19 AstraZeneca Common Stock Conversion Aquire C No 0 14,225,324 0 14,225,334
7 Oct 19 AstraZeneca Series A-1 Preferred Stock Common Stock Conversion Dispose C No 0 14,225,324 0 0
13F holders
Current Prev Q Change
Total holders 0 1 EXIT
Opened positions 0 0
Closed positions 1 0 NEW
Increased positions 0 1 EXIT
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 1.06M EXIT
Total shares 0 11.74K EXIT
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Parametric Portfolio Associates 0 -11.74K EXIT
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
6th grade Avg
New words: accuracy, alter, antagonist, Asia, atenolol, belong, Brexit, Breztri, Building, built, chemoradiation, chlorthalidone, chronic, CLL, communicated, communicating, communication, comparison, complex, constipation, critical, CVOT, DBTCA, dealing, depend, Description, Deutsche, device, dipeptidyl, directed, DOJ, Duaklir, earlier, effort, erosion, ESPC, fiscal, forecasted, formulary, headroom, heavily, highly, historical, hospital, hydrochlorothiazide, identification, Inderal, inflation, inquiry, intervene, Israel, Italy, judgement, judgment, jurisdiction, leukaemia, likelihood, lisinopril, long, lymphocytic, mandated, manner, Medicare, method, methodology, monitoring, mortality, naloxegol, NHSA, OIC, outcome, Pacific, PAMORA, peak, peripherally, point, Prasco, processed, procurement, projected, propranolol, protein, Purpose, quantified, range, realised, reappointment, recognise, recognised, reconciling, recoverability, recoverable, RedHill, regaining, relied, retail, retrospective, role, segment, sensitive, sensitivity, skill, SLL, slower, small, software, sought, specialised, successor, tam, technical, Tenoretic, Tenormin, transport, trust, turn, unauthorised, uncontrolled, unexpected, unlawful, unsettled, variable, whistleblower, Zestoretic, Zestril
Removed: Achieve, acquired, addressed, adjusted, adjustment, agree, alliance, Almirall, amortisation, amounting, applied, approve, arose, arrive, asset, auditing, balance, BMS, bond, broadly, calculated, chemotherapy, CHMP, column, comparative, copy, cost, credit, daily, decision, decrease, deferred, depreciation, detailed, disagreement, disclaimer, dismissed, disposal, divided, dollar, element, employer, ending, EPS, euro, Excluded, Externalisation, fair, finance, foregoing, formal, furnish, hedging, herewith, HQ, invest, investment, joint, June, KPMG, low, lower, manufacturing, margin, MedImmune, modified, olaparib, option, organisation, owing, participated, principally, proceeding, prohibited, propose, proposed, PwC, receivable, reduced, remeasurement, removing, repaid, reportable, requested, resolved, Rest, restructuring, retirement, rotation, royalty, satisfaction, scientific, scope, serve, spend, stating, transfer, trial, UKLA, unauthorized, unsuccessful, unwind, venture, York, ZS

Proxies

No filings